Can You Take Truvada and Valtrex Together?
Yes, Truvada (emtricitabine/tenofovir disoproxil fumarate) can be taken concurrently with Valtrex (valacyclovir) without clinically significant drug interactions.
No Known Drug Interactions
The FDA drug label for Truvada explicitly addresses drug interactions and does not list valacyclovir (Valtrex) as a contraindicated or cautionary medication 1. The label states that emtricitabine and tenofovir are primarily excreted by the kidneys through glomerular filtration and active tubular secretion, and notes: "No drug-drug interactions due to competition for renal excretion have been observed" 1.
Key Considerations for Safe Concurrent Use
Renal Function Monitoring
Both medications are renally excreted, so monitoring is prudent:
- Check baseline creatinine clearance before starting this combination
- Monitor renal function every 3-6 months during concurrent therapy, particularly if you have pre-existing renal impairment or other risk factors 1
- Avoid concurrent nephrotoxic agents (e.g., high-dose or multiple NSAIDs) which could compound renal stress 1
When to Exercise Caution
The combination requires closer monitoring if you have:
- Estimated creatinine clearance <60 mL/min
- History of renal disease
- Concurrent use of other renally-cleared medications
- Age >50 years with multiple comorbidities
Dosing Adjustments
- Truvada: Requires dose adjustment if creatinine clearance is 30-49 mL/min; contraindicated if <30 mL/min 1
- Valtrex: Also requires dose reduction in renal impairment per its prescribing information
Clinical Context Matters
For HIV treatment or PrEP: Current guidelines 2, 3 recommend Truvada-based regimens without restrictions regarding concurrent herpes suppression therapy. The combination is routinely used in clinical practice.
For hepatitis B with herpes coinfection: Truvada provides dual benefit for HBV treatment while Valtrex addresses HSV, making this a rational combination 1.
Bottom Line
This is a safe and commonly used combination in clinical practice. The primary concern is additive renal effects rather than a direct drug-drug interaction, which is easily managed through routine renal function monitoring.